Review of the animal pharmacology and pharmacokinetics of fluvoxamine

British Journal of Clinical Pharmacology
V Claassen

Abstract

1 Fluvoxamine maleate is a compound from the series of 2-aminoethyloximethers of aralkylketones which possesses marked inhibition effects on 5-hydroxytryptamine (5-HT) uptake by blood platelets and brain synaptosomes. In contrast, it has no effect on noradrenaline uptake processes. 2 Fluvoxamine is completely absorbed in rats and dogs; the main metabolic path was similar in rat, dog, hamster, mouse and rabbit. The metabolites of fluvoxamine are inactive with regard to aminergic uptake processes. 3 Fluvoxamine is neither sedative nor stimulating, shows a very low cardiotoxic effect and no affinity for the cholinergic receptor. On the basis of the pharmacological profile, a highly favourable therapeutic ratio of antidepressant effects vs disturbing side-effects is predicted.

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·G BertschyR Volmat
Jan 1, 1991·Biological Psychiatry·D J KupferA B McEachran
Sep 13, 1988·European Journal of Pharmacology·B M BaronM W Dudley
Jul 1, 1988·Journal of Affective Disorders·P L DelgadoG R Heninger
Jul 1, 1992·General Pharmacology·C el RawadiY Cohen
May 1, 1997·Pharmacology, Biochemistry, and Behavior·M G CutlerJ E Jackson
Jul 27, 1999·Pharmacology, Biochemistry, and Behavior·J C WinterR A Rabin
Feb 16, 2000·Pharmacology & Therapeutics·C Hiemke, S Härtter
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Meera VaswaniSubramanyam Ramesh
Jun 6, 2007·BioPsychoSocial Medicine·Akira OishiNoriyuki Inaba
Jun 27, 2009·Neuropsychiatric Disease and Treatment·Lídia OrdacgiLeonardo F Fontenelle
Feb 5, 2002·CNS Drugs·Susan M Cheer, David P Figgitt
Nov 9, 2001·The International Journal of Neuroscience·Y KanedaT Ohmori
Jan 1, 1985·Current Medical Research and Opinion·U A SiddiquiD K Jesinger
Jan 7, 2015·The Journal of Toxicological Sciences·Yukiko Yamazaki-HashimotoAtsushi Sugiyama
Mar 11, 2004·Psychiatry and Clinical Neurosciences·Toshiko KamoYasuhiko Maebashi
Jan 1, 1983·British Journal of Clinical Pharmacology·S CellaE E Müller
Nov 1, 1986·British Journal of Clinical Pharmacology·K DemischR Rieth
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·D R NelsonA M Johnson
Dec 3, 2014·European Journal of Pharmacology·Berend Olivier
Mar 27, 2015·Parkinson's Disease·Philippe HuotJonathan M Brotchie
May 1, 1993·Biopharmaceutics & Drug Disposition·M H De VriesM Raghoebar
Jul 1, 1989·Biomedical Chromatography : BMC·J Pommery, M Lhermitte
Apr 3, 2003·Human Psychopharmacology·Shigeru Morishita, Seizaburo Arita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.